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Abstract: Two new daphnicyclidin-type Daphniphyllum alkaloids, daphmacrodins A and B (1 and 2) were isolated from the leaves 
and stems of Daphniphyllum macropodum. Their structures were elucidated by extensive spectroscopic techniques, including 2D 
NMR spectroscopy and mass spectrometry. The relative configuration of 1 was further confirmed by a single-crystal X-ray  
diffraction analysis. Their cytotoxic activities against five human cancer cell lines, pesticidal activities against brine shrimp  
(Artemia salina), and antibacterial activities against five standard bacterial and fungal strains were evaluated. The structure of 1 was 
successfully transformed to 2 by a chemical method. 
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Introduction 
Daphniphyllum alkaloids are a family of diversified and 
complex polycyclic natural products elaborated by plants of 
the genus Daphniphyllum.1 Their unique structural features 
have attracted great interest as challenging targets for total 
synthesis2 and biosynthetic research3 for several decades. In 
recent years, quite a number of new Daphniphyllum alkaloids 
have been isolated and identified, and some of them possessed 
novel skeletons.4 In our continuing search for structurally 
unique Daphniphyllum alkaloids,4b–4d two new daphnicyclidin-
type compounds,5 daphmacrodins A and B (1 and 2) with rare 
cyclopentadienyl anion6 were isolated from the leaves and 
stems of D. macropodum. We report herein the isolation, 
structural elucidation, and the bioactivities of these two  
alkaloids. 
 
Results and Discussion 
Daphmacrodin A (1) was obtained as colorless monoclinic 
crystals (MeOH) with [α] 22D   + 155 (c 0.19, MeOH). The 
molecular formula, C22H23NO4, was established by positive 
HRESIMS (m/z 388.1528 [M + Na]+, calcd for C22H23NO4Na, 
388.1524), corresponding to 12 degrees of unsaturation. The 
IR absorption spectrum showed the presence of conjugated 
carbonyl (1668 and 1600 cm–1) functionality. The 13C NMR 
and DEPT data (Table 1) revealed 22 carbon signals 
comprising six sp2 carbon atoms (including one imine carbon 
atom), three carbonyl groups, and 13 sp3 carbon atoms (1 × C, 
3 × CH, 7 × CH2, 2 × CH3). Among them, two methylenes (C 
63.1 and 51.9) were ascribed as attached to a nitrogen atom, 
while one methylene (C 66.2) was ascribed as bearing an 
oxygen atom. Since nine sp2 quaternary carbons accounted for 
six out of 12 unsaturation, the remaining six degrees of 
unsaturation were assumed for the presence of a hexacyclic 
system in 1. 
 
Figure 1.  Structures of 1 and 2 
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Detailed analysis of 2D NMR (HSQC, 1H-1H COSY, and 
HMBC experiments, Fig. 2) revealed that 1 had a 
daphnicyclidin-type skeleton and possessed three spin 
coupling systems, a: H-3/H-2/H-18/H-19 (Me-20), b: H-7/H-
6/H-12/H-11 and c: H-16/H-17 (Fig. 2A). In the HMBC 
spectrum, cross-peaks of H-19 (H 4.00, dd, J = 14.0, 7.5 Hz; 
H 3.20, dd, J = 14.0, 9.0 Hz) to C-7 (C 63.1) indicated that 
the fragments a and b were connected through the nitrogen 
atom. The linkages of C-21, C-4, C-6, and C-8 to C-5 were 
fixed by the HMBC correlations from Me-21 (H 1.69, s) to C-
5 (C 58.3), C-6 (C 44.0) and C-8 (C 128.8); H-6 (H 2.80, m) 
to C-5 and C-8; H-3 (H 3.57, dd, J =  13.5, 2.5 Hz; H 2.74, 
dd, J = 13.5, 2.5 Hz) to C-4 (C 196.7) and C-5 . Moreover，
the HMBC correlations from H-11 (H 2.37, dd, J = 18.5, 6.5 
Hz) to C-9 (117.7) and H-16 (2.65, m) to C-9 revealed that 
fragments b and c were linked through C-10-C-9-C-15 
fragment. The attachment of C-1 to C-2 as well as C-11 to C-
10 were established by HMBC cross-peaks of H-2 (H 2.86, m) 
to C-1 (C 193.6) and H-11 (H 2.63, m) to C-10 (C 197.6), 
respectively. Ring E was fused to rings C and D through the 
cyclopentadienyl anion ring was eventually resolved by the X-
ray diffraction analysis (Fig. 3). Thus, the planar structure of 1 
was established as a hexacyclic framework (Fig. 1). The β 
orientation of H-2, Me-20, Me-21 and H-6 was deduced from 
ROESY correlations of Me-20/H-2, Me-20/H-3b, H-3b/Me-21, 
Me-21/H-6, which was further confirmed by the results of 
single-crystal X-ray diffraction analysis.  
Daphnicyclidin B (2), possesses a molecular formula of 
C22H25NO4 determined by positive HRESIMS (m/z 368.1861 
[M + H]+, calcd for C22H26NO4, 368.1861) and 11 degrees of 
unsaturation. The NMR data showed high similarity to those 
of 1, except that the quaternary carbon C-4 (C 196.7) was 
replaced by a methine carbon at C 66.4. This assignment was 
confirmed by 1H-1H COSY and HMBC spectra (Fig. 2), 
especially by the HMBC correlations from H-7 (H 3.81, t, J = 
11.0 Hz; 2.73, m) and H-19 (H 3.16, m) to C-4 (C 66.4) (Fig. 
2B). The β-oriented H-4 (H 3.53, br. s) was fixed by the 
ROESY correlations between H-4 and Me-21 (H 1.36, s). 
Further detailed analysis of the 2D NMR (HSQC, 1H-1H 
COSY, and HMBC experiments) revealed that the rest part of 
2 was in agreement with 1. Hence, the structure of 2 was 
established as shown in Fig. 1. 
To investigate the structural relationship between 1 and 2, 
compound 1 was quantificationally transformed into 2 by 
reduction of the imine group in 1 according to reported 
method7 (Scheme 1). 
Compounds 1 and 2 were assayed in vitro for pesticidal  
activity against brine shrimp (Artemia salina) by the previously
described Microwell method,8 for their cytotoxicity against 
five human cancer cell lines (HL-60, SMMC-7721, A-549, 
MCF-7 and SW-480) using the MTT method9 with cisplatin 
and paclitaxel as positive controls, and for bacteriostatic  
activity against (ATCC25923, ATCC27853, MRSA 92, and 
MRSA 98 by two-fold dilution method,10 while no positive 
results were observed at concentrations of 50 and 100 μg/mL. 
 
Experimental Section 
General Experimental Procedures. Melting points were 
measured on a Yuhua X-4 digital microdisplaying Melting 
Point Apparatus. Optical rotations were measured with a Jasco 
P-1020 polarimeter. UV spectra were obtained using a  
Shimadzu UV-2401A spectrophotometer. CD spectra were 
recorded with an Applied Photophysics Chirascan spectrometer.
A Tenor 27 spectrophotometer was used for IR spectra as KBr 
pellets. 1D and 2D NMR spectra were recorded on Bruker 
DRX-500 spectrometer with TMS as internal standard. 
HRESIMS was performed on an API QSTAR time-of-flight 
Table 1. 13C NMR spectroscopic data for daphmacrodins A 
and B (1 and 2) 
pos. 1a 2a pos. 1a 2a 
1 193.6 C 194.6 C 12 25.8b CH2 27.5 CH2 
2 52.0 CH 47.1 CH 13 121.9 C 122.5 C 
3 25.8b CH2 17.0 CH2 14 112.1 C 112.3 C 
4 196.7 C 66.4 CH 15 138.0 C 139.1 C 
5 58.3 C 49.9 C 16 25.2 CH2 25.3 CH2 
6 44.0 CH 47.6 CH 17 66.2 CH2 65.8 CH2 
7 63.1 CH2 59.3 CH2 18 34.2 CH 28.5 CH 
8 128.8 C 133.5 C 19 51.9 CH2 52.9 CH2 
9 117.7 C 120.5 C 20 18.7 CH3 16.7 CH3 
10 197.6 C 198.8 C 21 28.3 CH3 35.1 CH2 
11 39.5 CH2 39.5 CH2 22 161.8 C 162.0 C 
aRecorded in DMSO-d6 at 125 MHz 
bOverlapped 
 
Figure 2.  1H-1H COSY (Bold) and key HMBC correlations of 
1 (A) and 2 (B) 
 
Scheme 1.  Reduction of 1 into 2 
 
Figure 3.  Crystal X-ray structure of 1 
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spectrometer. X-ray data were collected using a Bruker APEX 
DUO instrument. Semipreparative HPLC was performed on an 
Agilent 1100 liquid chromatograph with a Waters X-Bridge 
C18 (4.6 × 250 mm) column. Column chromatography (CC) 
were performed using silica (200–300 mesh and 300–400 
mesh, Qingdao Marine Chemical, Inc., Qingdao, China) and 
Sephadex LH-20 (40–70 m, Amersham Pharmacia Biotech 
AB, Uppsala, Sweden). 
 
Plant Material. The leaves and stems of D. macropodum 
were collected from Sichuan Province, China, in October 2010. 
The plant samples were identified by Prof. Liangke Song of 
the School of Life Science and Engineering, Southwest  
Jiaotong University (SWJTU). A voucher specimen (KIB 
H20101011) was deposited at the State Key Laboratory of 
Phytochemistry and Plant Resource in West China, Kunming 
Institute of Botany, Chinese Academy of Science (CAS). 
 
Extraction and Isolation. The air-dried, powdered leaves 
and stems (34 kg) of D. macropodum were extracted three 
times with 95% EtOH. The extract was adjusted with saturated 
tartaric acid to pH 2–3 and then defatted with petroleum ether 
(PE). Next, the aqueous phase was adjusted to pH 10 with 
saturated Na2CO3 and extracted with CHCl3 to obtain the crude 
alkaloid fraction (260 g). The total alkaloid was subjected to 
normal phase Si gel (200–300 mesh; CHCl3/MeOH, 1:0→0:1) 
to obtain five major fractions (Fr. 1–5). Fraction 4 (Fr. 4, 30 g) 
was further chromatographed over a reverse phase medium 
pressure column (MeOH/H2O, 1:1→1:0) to give four fractions 
(Fr. 4A–4E). Fraction 4E (8.0 g) was subjected to normal 
phase Si gel (300–400 mesh; CHCl3/MeOH = 25:1) to obtain 
seven fractions (Fr. 4E1–4E7). Fr. 4E7 was again separated by 
normal phase Si gel (300–400 mesh; CHCl3/MeOH = 5:1) to 
give compounds 1 (30 mg) and 2 (4 mg). 
 
Daphmacrodin A (1): colorless crystals; mp 136.0–
137.0 °C; [α]22D   + 155 (c 0.19, MeOH); UV (MeOH) λmax (log ε) 
203 (3.33), 292 (3.55), 361 (3.17); CD (0.00026 M, MeOH) 
λmax () 292 (–18.43) nm; IR (KBr) νmax 3439, 2928, 1668, 
1600, 1458, 1351, 1310, 1109, 1019 and 785 cm–1; 1H and 13C 
NMR data, Tables 2 and 1; positive ESIMS m/z 366 [M + H]+, 
388 [M + Na]+; positive HRESIMS [M + Na]+ m/z 388.1528, 
calcd 388.1524. 
 
Daphmacrodin B (2): white powder; [α]22D   + 200 (c 0.07, 
MeOH); UV (MeOH) λmax (log ε) 203 (3.57), 297 (3.85), 362 
(3.53); CD (0.00027 M, MeOH) λmax () 292 (16.69) nm; IR 
(KBr) νmax 3428, 2927, 1659, 1607, 1455, 1348, 1232, 1076, 
1047, 1018 and 785 cm–1; 1H and 13C NMR data, Tables 2 and 
1; positive ESIMS m/z 368 [M + H]+, 390 [M + Na]+; positive 
HRESIMS [M + H]+ m/z 368.1861, calcd 368.1861. 
 
Reduction of 1 into 2: A solution of 1 (5.0 mg) in  
anhydrous isopropanol (2 mL) was treated with sodium  
borohydride (1.6 mg, 3.08 eq.) The reaction mixture was 
stirred at 85 C for 24 h in sealed tube. Then 0.1 mL saturated 
ammonium chloride aqueous was added and stirred for 1 h. 
The isopropanol was removed under diminished pressure and 
the residue was partitioned in CHCl3/H2O = 1:1 (total 10 mL). 
The organic extracts were combined and the solvent was  
removed to give solid 2 (5.0 mg, 99.4%) which was  
determined by TLC analysis and negative ESIMS spectrum 
comparison with that of natural source of daphmacrodin B. 
 
X-ray Crystal Structure Analysis. Colorless crystals of 1 
were obtained from MeOH. Intensity data were collected at 
room temperature on a Bruker APEX DUO diffractometer 
equipped with an APEX II CCD using Mo Kα radiation. Cell 
refinement and data reduction were performed with Bruker 
SAINT Software. The structure was solved by direct methods 
using SHELXL-97.11 Refinements were performed with 
SHELXL-97 using full-matrix least-squares, with anisotropic 
displacement parameters for all the non-hydrogen atoms. The 
H-atoms were placed in calculated positions and refined using 
a riding model. Molecular graphics were computed with 
PLATON. Crystal data: C23H27NO5 (containing one MeOH 
molecular), tetragonal space group P21, a = 7.0149(9) Å，b = 
11.4350(14) Å， c = 12.2778(15) Å, α = γ = 90  = 
95.218(2), V = 980.8(2) Å3, Z = 2, Dx = 1.346 kg m3. Crystal-
lographic data (excluding structure factor tables) for 1 were 
deposited with the Cambridge Crystallographic Data Center as 
supplementary publication No. CCDC 865586. Copies of the 
data can be obtained free of charge by application to CCDC, 
12 Union Road, Cambridge CB 1EZ, UK [fax: Int. +44 (0) 
(1223) 336 033; e-mail: deposit@ccdc.cam.ac.uk] 
 
Electronic Supplementary Material 
Supplementary material is available in the online version of 
this article at http://dx.doi.org/ 10.1007/s13659-012-0095-z 
and is accessible for authorized users. 
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